Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Liu, Wei ^a   Wan, Jing ^a   Han, Jian Zhong ^a   Li, Chen ^a,c   Feng, Dan Dan ^a   Yue, Shao Jie ^b   Huang, Yan Hong ^a   Chen, Yi ^a   Cheng, Qing Mei ^a   Li, Yang ^a   Luo, Zi Qiang ^a  

^a The First People s Hospital of Changde City)   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

Antiflammin 1; Bleomycin; Pulmonary fibrosis; Uteroglobin receptor

Indexed keywords

ANTIFIBROTIC AGENT; ANTIFLAMMIN; ANTIFLAMMIN 1; ANTIINFLAMMATORY AGENT; BLEOMYCIN; BROMODEOXYCYTIDINE; COLLAGEN; CYCLIN D1; HYDROXYPROLINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIFLAMMIN P1; PEPTIDE FRAGMENT; UTEROGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG HOMOGENATE; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; SURVIVAL RATE; WEIGHT REDUCTION; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; FIBROBLAST; LUNG; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLEOMYCIN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FIBROBLASTS; HYDROXYPROLINE; INTERLEUKIN-1BETA; LUNG; MALE; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UTEROGLOBIN;

EID: 84885005165     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-101     Document Type: Article

References (38)

1. O'Connell OJ, Kennedy MP, Henry MT. Idiopathic pulmonary fibrosis: treatment update. Adv Ther 2011, 28:986-99. 10.1007/s12325-011-0066-5, 21975927.
2. Mukherjee AB, Zhang Z, Chilton BS. Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Endocr Rev 2007, 28:707-25. 10.1210/er.2007-0018, 17916741.
3. Wang H, Long XB, Cao PP, Wang N, Liu Y, Cui YH, Huang SK, Liu Z. Clara cell 10-kD protein suppresses chitinase 3-like 1 expression associated with eosinophilic chronic rhinosinusitis. Am J Respir Crit Care Med 2010, 181:908-16. 10.1164/rccm.200904-0597OC, 2862304, 20093645.
4. Szabo E, Goheer A, Witschi H, Linnoila RI. Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 1998, 9:475-85.
5. Zhang Z, Kundu GC, Panda D, Mandal AK, Mantile-Selvaggi G, Peri A, Yuan CJ, Mukherjee AB. Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene. Proc Natl Acad Sci U S A 1999, 96:3963-8. 10.1073/pnas.96.7.3963, 22403, 10097146.
6. Yang SH, Shin SJ, Oh JE, Jin JZ, Chung NH, Lim CS, Kim S, Kim YS. The protective role of uteroglobin through the modulation of tissue transglutaminase in the experimental crescentic glomerulonephritis. Nephrol Dial Transplant 2008, 23:3437-45. 10.1093/ndt/gfn268, 18558621.
7. Li C, Hu W, Han J, Shen L, Yue S, Feng D, Luo Z. Clara cells ablation increases Ki67 immunoexpression and histological grade in bleomycin lung [abstract]. Regul Peptides 2006, 135:141-141.
8. Lee YC, Zhang Z, Mukherjee AB. Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosis. FEBS Lett 2006, 580:4515-20. 10.1016/j.febslet.2006.07.031, 16872605.
9. Miele L, Cordella-Miele E, Facchiano A, Mukherjee AB. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 1988, 335:726-30. 10.1038/335726a0, 2971881.
10. Miele L. Antiflammins. Bioactive peptides derived from uteroglobin. Ann N Y Acad Sci 2000, 923:128-40.
11. Zouki C, Ouellet S, Filep JG. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J 2000, 14:572-80.
12. Han J, Li C, Liu H, Fen D, Hu W, Liu Y, Guan C, Luo ZQ. Inhibition of lipopolysaccharide-mediated rat alveolar macrophage activation in vitro by antiflammin-1. Cell Biol Int 2008, 32:1108-15. 10.1016/j.cellbi.2008.04.023, 18541446.
13. Lloret S, Moreno JJ. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation. Eur J Pharmacol 1994, 264:379-84. 10.1016/0014-2999(94)00500-1, 7535228.
14. Gao J, Zhao J, Rayner SE, Van Helden DF. Evidence that the ATP-induced increase in vasomotion of guinea-pig mesenteric lymphatics involves an endothelium-dependent release of thromboxane A2. Br J Pharmacol 1999, 127:1597-602. 10.1038/sj.bjp.0702710, 1566155, 10455315.
15. Vostal JG, Mukherjee AB, Miele L, Shulman NR. Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion. Biochem Biophys Res Commun 1989, 165:27-36. 10.1016/0006-291X(89)91029-2, 2531581.
16. Chan CC, Ni M, Miele L, Cordella-Miele E, Ferrick M, Mukherjee AB, Nussenblatt RB. Effects of antiflammins on endotoxin-induced uveitis in rats. Arch Ophthalmol 1991, 109:278-81. 10.1001/archopht.1991.01080020124058, 1993038.
17. Lloret S, Moreno JJ. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. Biochem Pharmacol 1992, 44:1437-41. 10.1016/0006-2952(92)90546-U, 1417964.
18. Mize NK, Buttery M, Ruis N, Leung I, Cormier M, Daddona P. Antiflammin 1 peptide delivered non-invasively by iontophoresis reduces irritant-induced inflammation in vivo. Exp Dermatol 1997, 6:181-5. 10.1111/j.1600-0625.1997.tb00203.x, 9293390.
19. Merrifield RB. Solid phase peptide synthesis. I: the synthesis of a tetrapeptide. J Am Chem Soc 1963, 85:2149-54.
20. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988, 41:467-70. 10.1136/jcp.41.4.467, 1141479, 3366935.
21. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 2006, 173:769-76. 10.1164/rccm.200505-717OC, 16415276.
22. Li C, Han J, Li L, Yue S, Li J, Feng D, Liu H, Jiang D, Qin X, Luo Z. Interaction of antiflammin-1 with uteroglobin-binding protein induces phosphorylation of ERK1/2 in NIH 3T3 cells. Peptides 2007, 28:2137-45. 10.1016/j.peptides.2007.08.027, 17928103.
23. Mouratis MA, Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 2011, 17:355-61. 10.1097/MCP.0b013e328349ac2b, 21832918.
24. Imazu Y, Yanagi S, Miyoshi K, Tsubouchi H, Yamashita S, Matsumoto N, Ashitani J, Kangawa K, Nakazato M. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation. Eur J Pharmacol 2011, 672:153-8. 10.1016/j.ejphar.2011.09.183, 21996315.
25. Yang HZ, Wang JP, Mi S, Liu HZ, Cui B, Yan HM, Yan J, Li Z, Liu H, Hua F, Lu W, Hu ZW. TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. Am J Pathol 2012, 180:275-92. 10.1016/j.ajpath.2011.09.019, 22062220.
26. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int J Biochem Cell Biol 2008, 40:362-82. 10.1016/j.biocel.2007.08.011, 2323681, 17936056.
27. Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012, 9:111-6. 10.1513/pats.201203-023AW, 22802283.
28. Stacey DW, Hitomi M. Cell cycle studies based upon quantitative image analysis. Cytometry A 2008, 73:270-8.
29. Biggar KK, Storey KB. Evidence for cell cycle suppression and microRNA regulation of cyclin D1 during anoxia exposure in turtles. Cell Cycle 2012, 11:1705-13. 10.4161/cc.19790, 22510561.
30. De Vita F, Riccardi M, Malanga D, Scrima M, De Marco C, Viglietto G. PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest. Cell Cycle 2012, 11:1583-92. 10.4161/cc.20003, 22441823.
31. Kundu GC, Mantile G, Miele L, Cordella-Miele E, Mukherjee AB. Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding site. Proc Natl Acad Sci U S A 1996, 93:2915-9. 10.1073/pnas.93.7.2915, 39734, 8610142.
32. Kundu GC, Mandal AK, Zhang Z, Mantile-Selvaggi G, Mukherjee AB. Uteroglobin (UG) suppresses extracellular matrix invasion by normal and cancer cells that express the high affinity UG-binding proteins. J Biol Chem 1998, 273:22819-24. 10.1074/jbc.273.35.22819, 9712916.
33. Kundu GC, Zhang Z, Mantile-Selvaggi G, Mandal A, Yuan CJ, Mukherjee AB. Uteroglobin binding proteins: regulation of cellular motility and invasion in normal and cancer cells. Ann N Y Acad Sci 2000, 923:234-48.
34. Wojnar P, Lechner M, Merschak P, Redl B. Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display. J Biol Chem 2001, 276:20206-12. 10.1074/jbc.M101762200, 11287427.
35. Zhang Z, Kim SJ, Chowdhury B, Wang J, Lee YC, Tsai PC, Choi M, Mukherjee AB. Interaction of uteroglobin with lipocalin-1 receptor suppresses cancer cell motility and invasion. Gene 2006, 369:66-71.
36. Moreno JJ. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase. Int Immunopharmacol 2006, 6:300-3. 10.1016/j.intimp.2005.08.001, 16399636.
37. Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ. Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184:699-707. 10.1164/rccm.201101-0013OC, 3208598, 21700912.
38. Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, Kim YS, Melino G, Kim IG, Lee DS. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med 2011, 208:1707-19. 10.1084/jem.20101457, 3149214, 21746810.